Home
About Us
Resource Library
Site
Polio and prevention
Infected countries
Data and monitoring
Post-eradication
Research
Financing
Media room
You are here:
Research
>
Frequently asked questions
OPV efficacy
OPV delivery
Affordable IPV
Vaccine-derived polioviruses
Frequently asked questions
Polio Pipeline
Polio Research Committee
Grants and collaboration
Antivirals
Frequently asked questions
Q1. What are the quality and safety standards that the World Health Organization (WHO) polio research abides by, and must these be applied to external research supported by the Polio Research Committee (PRC)?
Q2. What are the principal review criteria by the Polio Research Committee (PRC) on submitted research proposals?
Q3. Why not continue oral polio vaccine (OPV) indefinitely in the post-eradication era?
Q4. What is the role of inactivated polio vaccine (IPV) following OPV cessation?
Q5. Why not use IPV instead of OPV to eliminate the problem of cVDPVs?
research